Yüklüyor......
Alectinib Salvages CNS Relapses in ALK-Positive Lung Cancer Patients Previously Treated with Crizotinib and Ceritinib
BACKGROUND: Leptomeningeal metastases (LM) are an increasingly frequent and devastating complication of anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer (NSCLC). Currently, the optimal management of LM in ALK-positive patients remains poorly understood as these patients have be...
Kaydedildi:
| Yayımlandı: | J Thorac Oncol |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4304931/ https://ncbi.nlm.nih.gov/pubmed/25526238 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0000000000000455 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|